Which of the following techniques may be used for pain management for a child having an intramuscular injection?

Pediatric pain management for intramuscular injections relies on non-pharmacologic interventions and topical/local anesthetics to reduce nociceptive transmission, anxiety response, and procedural distress. Effective strategies target both psychological and peripheral pain pathways.

Rationale:

A. Use of an 18–20g needle is incorrect because larger gauge needles increase tissue trauma and pain intensity. Pediatric IM injections require smaller gauge needles appropriate for muscle mass to minimize nociceptor stimulation and reduce procedural discomfort.

B. Distraction techniques such as play, conversation, or visual engagement reduce perceived pain by redirecting cortical attention. This modulates pain perception through central gating mechanisms and is a validated non-pharmacological analgesic strategy in pediatric care.

C. Chug position is not a recognized evidence-based pediatric pain management technique. Proper positioning may aid immobilization, but this term does not represent a standard intervention for reducing procedural pain or anxiety in children.

D. Oral analgesics are not typically used acutely for IM injection pain prevention due to delayed onset. They are ineffective for immediate procedural pain control and do not provide adequate local anesthesia at the injection site.

E. Administering injection slowly does not reduce pain; it may prolong tissue exposure and increase discomfort. Optimal technique involves swift, controlled administration to minimize duration of nociceptive stimulation and reduce anxiety associated with prolonged procedure time.

F. EMLA cream provides topical local anesthesia by blocking sodium channels in dermal nerves. When applied prior to injection, it significantly reduces procedural pain and is widely used in pediatric settings for IM and venipuncture procedures.